No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MXL240816C22500
- 2.51
- -0.79-23.94%
15min DelayClose Jul 22 10:44 ET
2.51High2.51Low
2.51Open3.30Pre Close1 Volume26 Open Interest22.50Strike Price251.00Turnover61.40%IV-0.20%PremiumAug 16, 2024Expiry Date2.56Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7790Delta0.0732Gamma7.83Leverage Ratio-0.0262Theta0.0113Rho6.10Eff Leverage0.0196Vega
Intraday
- 5D
- Daily
News
6 Stocks That Have Come Too Far, Too Fast -- Barrons.com
By Jacob Sonenshine Small-caps stocks are coming off a rally for the record books -- and it's time to take profits in some of the biggest winners. The Russell 2000 index of small-cap stocks is
Craig-Hallum Maintains MaxLinear(MXL.US) With Buy Rating, Maintains Target Price $38
Craig-Hallum analyst Richard Shannon maintains $MaxLinear(MXL.US)$ with a buy rating, and maintains the target price at $38.According to TipRanks data, the analyst has a success rate of 43.3% and a
Is MaxLinear, Inc. (NASDAQ:MXL) Trading At A 46% Discount?
MaxLinear Is Maintained at Buy by Stifel
MaxLinear Is Maintained at Buy by
Stifel Maintains MaxLinear(MXL.US) With Buy Rating, Raises Target Price to $30
Stifel analyst Tore Svanberg maintains $MaxLinear(MXL.US)$ with a buy rating, and adjusts the target price from $26 to $30.According to TipRanks data, the analyst has a success rate of 64.8% and a
Express News | Maxlinear Inc : Stifel Raises Target Price to $30 From $26
Comments
The decline in share price and revenue indicates unresolved challenges for MaxLinear. Investors may be hoping for future growth or cost cutting. However, long term share price weakness can be a bad sign, suggesting a need for a turnaround.
MaxLinear (NASDAQ:MXL) Shareholders Are up 8.8% This Past Week, but Still in the Red Over the Last Year 1
MaxLinear's net cash position suggests a light debt load, but future earnings will determine its balance sheet health. The company's shrinking revenue and pre-interest, pre-tax loss over the past year are worrisome. Despite positive free cash flow, the absence of positive EBIT makes the stock somewhat risky.
MaxLinear's lower P/S suggests the market is not optimistic about the firm's future revenue growth. Further decline in revenues may push the P/S lower, possibly hindering any significant rise in stock price in the near term.
MaxLinear's performance and decline in revenue point to a need for growth or cost-cutting to draw investment interest. Its underperformance this year against a 0.9% annual loss over five years invites scrutiny before investment.
3
$MaxLinear(MXL.US$ on move ! good job all
Read more